625 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: analysis of progression-free survival and overall survival outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
M. Mirza, Sudarshan Sharma, Jørn Herrstedt, M. Shahin, David Cibula, E. Fleming, F. Raspagliesi, J. Buscema, L. Hanker, Robert L Coleman, I. Boere, K. Schneider, L. Gilbert, B. Slomovitz, M. Teneriello, M. Powell, Srimoyee Ghosh, S. Stevens, K. Ring, A. Stuckey
{"title":"625 Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: analysis of progression-free survival and overall survival outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","authors":"M. Mirza, Sudarshan Sharma, Jørn Herrstedt, M. Shahin, David Cibula, E. Fleming, F. Raspagliesi, J. Buscema, L. Hanker, Robert L Coleman, I. Boere, K. Schneider, L. Gilbert, B. Slomovitz, M. Teneriello, M. Powell, Srimoyee Ghosh, S. Stevens, K. Ring, A. Stuckey","doi":"10.1136/ijgc-2024-esgo.32","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"107 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
